AU4574800A - Galenic formulations of antithrombotic agents for subcutaneous administration - Google Patents

Galenic formulations of antithrombotic agents for subcutaneous administration

Info

Publication number
AU4574800A
AU4574800A AU45748/00A AU4574800A AU4574800A AU 4574800 A AU4574800 A AU 4574800A AU 45748/00 A AU45748/00 A AU 45748/00A AU 4574800 A AU4574800 A AU 4574800A AU 4574800 A AU4574800 A AU 4574800A
Authority
AU
Australia
Prior art keywords
subcutaneous administration
antithrombotic agents
galenic formulations
galenic
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45748/00A
Inventor
Frederic Andre
Alain Cuine
Gareth Lewis
Benedicte Roger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU4574800A publication Critical patent/AU4574800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU45748/00A 1999-05-11 2000-05-09 Galenic formulations of antithrombotic agents for subcutaneous administration Abandoned AU4574800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9905975 1999-05-11
FR9905975A FR2793418B1 (en) 1999-05-11 1999-05-11 GALENIC FORMULATIONS OF ANTITHROMBOTIC AGENTS FOR SUBCUTANEOUS ADMINISTRATION
PCT/FR2000/001245 WO2000067727A1 (en) 1999-05-11 2000-05-09 Galenic formulations of antithrombotic agents for subcutaneous administration

Publications (1)

Publication Number Publication Date
AU4574800A true AU4574800A (en) 2000-11-21

Family

ID=9545447

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45748/00A Abandoned AU4574800A (en) 1999-05-11 2000-05-09 Galenic formulations of antithrombotic agents for subcutaneous administration

Country Status (3)

Country Link
AU (1) AU4574800A (en)
FR (1) FR2793418B1 (en)
WO (1) WO2000067727A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902550D0 (en) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356732A (en) * 1966-03-29 1967-12-05 Gen Electric 2-[p-(phenylsulfonyl) phenyl]-1, 3-indanedione and its tautomer
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
CH673395A5 (en) * 1987-01-30 1990-03-15 Ciba Geigy Ag
US5534270A (en) * 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
SE9601556D0 (en) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
FR2761065B1 (en) * 1997-03-20 2000-03-03 Synthelabo N- (ARGINYL) BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
WO2000067727A1 (en) 2000-11-16
FR2793418A1 (en) 2000-11-17
FR2793418B1 (en) 2001-07-27

Similar Documents

Publication Publication Date Title
AU762322C (en) Novel galenic formulations of meloxicam for oral administration
WO2000007979A3 (en) Compounds and compositions for delivering active agents
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
EP1171117A4 (en) Long term administration of pharmacologically active agents
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
AU2274201A (en) Compounds and compositions for delivering active agents
AU4996300A (en) Method of electroporation-enhanced delivery of active agents
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
AU2623201A (en) Controlled delivery of therapeutic agents by insertable medical devices
AU3192700A (en) Medicinal compositions
AU3469400A (en) Pharmaceutical compositions for treatment of diseased tissues
AU2005300A (en) Medicinal compositions
WO2002015959A3 (en) Compounds and compositions for delivering active agents
AU6715600A (en) Pharmaceutical formulations
AU5838398A (en) Rapamycin formulations for oral administration
AU2564399A (en) Isoflavanoid formulations for oral administration
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU1068101A (en) Transdermal administration of reboxetine
AU4977300A (en) Pharmaceutical formulations
AU1385801A (en) Pharmaceutical formulations
AU2002253785A1 (en) Catheter and implants for the delivery of therapeutic agents to tissues
AU6503399A (en) Drug delivery catheter
AU4574800A (en) Galenic formulations of antithrombotic agents for subcutaneous administration

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase